Osteoclastogenesis and Osteoclastic Resorption of Tricalcium Phosphate: Effect of Strontium and Magnesium Doping

Overview

Journal J Biomed Mater Res A

Specialty Biomedical Engineering

Date 2012 May 9

PMID 22566212

Citations 30

Authors

Mangal Roy

Susmita Bose

Affiliations

Soon will be listed here.

Abstract

Bone substitute materials are required to support the remodeling process, which consists of osteoclastic resorption and osteoblastic synthesis. Osteoclasts, the bone-resorbing cells, generate from differentiation of hemopoietic mononuclear cells. In the present study, we have evaluated the effects of 1.0 wt % strontium (Sr) and 1.0 wt % magnesium (Mg) doping in beta-tricalcium phosphate (β-TCP) on the differentiation of mononuclear cells into osteoclast-like cells and its resorptive activity. In vitro osteoclast-like cell formation, adhesion, and resorption were studied using osteoclast precursor RAW 264.7 cell, supplemented with receptor activator of nuclear factor κβ ligand (RANKL). Osteoclast-like cell formation was noticed on pure and Sr-doped β-TCP samples at day 8, which was absent on Mg-doped β-TCP samples indicating decrease in initial osteoclast differentiation due to Mg doping. After 21 days of culture, osteoclast-like cell formation was evident on all samples with osteoclastic markers such as actin ring, multiple nuclei, and presence of vitronectin receptor α(v)β(3) integrin. After osteoclast differentiation, all substrates showed osteoclast-like cell-mediated degradation, however, significantly restricted for Mg-doped β-TCP samples. Our present results indicated that substrate chemistry controlled osteoclast differentiation and resorptive activity, which can be used in designing TCP-based resorbable bone substitutes with controlled degradation properties.

Citing Articles

Biomaterial Cues for Regulation of Osteoclast Differentiation and Function in Bone Regeneration.

Shariati K, Bedar M, Huang K, Moghadam S, Mirzaie S, LaGuardia J Adv Ther (Weinh). 2025; 8(1.

PMID: 39867107 PMC: 11756815. DOI: 10.1002/adtp.202400296.

3D printed scaffolds with quercetin and vitamin D3 nanocarriers: In vitro cellular evaluation.

Bose S, Chaudhari V, Kushram P J Biomed Mater Res A. 2024; 112(12):2110-2123.

PMID: 38894584 PMC: 11464199. DOI: 10.1002/jbm.a.37756.

In Vivo Investigation of 3D-Printed Calcium Magnesium Phosphate Wedges in Partial Load Defects.

Hemmerlein E, Vorndran E, Schmitt A, Feichtner F, Waselau A, Meyer-Lindenberg A Materials (Basel). 2024; 17(9).

PMID: 38730942 PMC: 11085615. DOI: 10.3390/ma17092136.

and properties evaluation of curcumin loaded MgO doped 3D printed TCP scaffolds.

Bhattacharjee A, Jo Y, Bose S J Mater Chem B. 2023; 11(21):4725-4739.

PMID: 37171110 PMC: 10314738. DOI: 10.1039/d2tb02547g.

Monocyte Differentiation on Atomic Layer-Deposited (ALD) Hydroxyapatite Coating on Titanium Substrate.

Kylmaoja E, Abushahba F, Holopainen J, Ritala M, Tuukkanen J Molecules. 2023; 28(8).

PMID: 37110845 PMC: 10143381. DOI: 10.3390/molecules28083611.

References

Banerjee S, Tarafder S, Davies N, Bandyopadhyay A, Bose S . Understanding the influence of MgO and SrO binary doping on the mechanical and biological properties of beta-TCP ceramics. Acta Biomater. 2010; 6(10):4167-74. DOI: 10.1016/j.actbio.2010.05.012. View

Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

Bose S, Tarafder S, Banerjee S, Davies N, Bandyopadhyay A . Understanding in vivo response and mechanical property variation in MgO, SrO and SiO₂ doped β-TCP. Bone. 2011; 48(6):1282-90. PMC: 3109736. DOI: 10.1016/j.bone.2011.03.685. View

Okuda T, Ioku K, Yonezawa I, Minagi H, Kawachi G, Gonda Y . The effect of the microstructure of beta-tricalcium phosphate on the metabolism of subsequently formed bone tissue. Biomaterials. 2007; 28(16):2612-21. DOI: 10.1016/j.biomaterials.2007.01.040. View

Janning C, Willbold E, Vogt C, Nellesen J, Meyer-Lindenberg A, Windhagen H . Magnesium hydroxide temporarily enhancing osteoblast activity and decreasing the osteoclast number in peri-implant bone remodelling. Acta Biomater. 2009; 6(5):1861-8. DOI: 10.1016/j.actbio.2009.12.037. View

Salo J, Lehenkari P, Mulari M, Metsikko K, Vaananen H . Removal of osteoclast bone resorption products by transcytosis. Science. 1997; 276(5310):270-3. DOI: 10.1126/science.276.5310.270. View

Li X, Ito A, Sogo Y, Wang X, LeGeros R . Solubility of Mg-containing beta-tricalcium phosphate at 25 degrees C. Acta Biomater. 2008; 5(1):508-17. PMC: 2630969. DOI: 10.1016/j.actbio.2008.06.010. View

Detsch R, Hagmeyer D, Neumann M, Schaefer S, Vortkamp A, Wuelling M . The resorption of nanocrystalline calcium phosphates by osteoclast-like cells. Acta Biomater. 2010; 6(8):3223-33. DOI: 10.1016/j.actbio.2010.03.003. View

Hoppe A, Guldal N, Boccaccini A . A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials. 2011; 32(11):2757-74. DOI: 10.1016/j.biomaterials.2011.01.004. View

10.

Teitelbaum S . Bone resorption by osteoclasts. Science. 2000; 289(5484):1504-8. DOI: 10.1126/science.289.5484.1504. View

11.

Patntirapong S, Habibovic P, Hauschka P . Effects of soluble cobalt and cobalt incorporated into calcium phosphate layers on osteoclast differentiation and activation. Biomaterials. 2008; 30(4):548-55. DOI: 10.1016/j.biomaterials.2008.09.062. View

12.

Detsch R, Mayr H, Ziegler G . Formation of osteoclast-like cells on HA and TCP ceramics. Acta Biomater. 2007; 4(1):139-48. DOI: 10.1016/j.actbio.2007.03.014. View

13.

Xia Z, Grover L, Huang Y, Adamopoulos I, Gbureck U, Triffitt J . In vitro biodegradation of three brushite calcium phosphate cements by a macrophage cell-line. Biomaterials. 2006; 27(26):4557-65. DOI: 10.1016/j.biomaterials.2006.04.030. View

14.

Enderle R, Gotz-Neunhoeffer F, Gobbels M, Muller F, Greil P . Influence of magnesium doping on the phase transformation temperature of beta-TCP ceramics examined by Rietveld refinement. Biomaterials. 2004; 26(17):3379-84. DOI: 10.1016/j.biomaterials.2004.09.017. View

15.

Yang L, Perez-Amodio S, Barrere-de Groot F, Everts V, van Blitterswijk C, Habibovic P . The effects of inorganic additives to calcium phosphate on in vitro behavior of osteoblasts and osteoclasts. Biomaterials. 2010; 31(11):2976-89. DOI: 10.1016/j.biomaterials.2010.01.002. View

16.

Xue W, Dahlquist K, Banerjee A, Bandyopadhyay A, Bose S . Synthesis and characterization of tricalcium phosphate with Zn and Mg based dopants. J Mater Sci Mater Med. 2008; 19(7):2669-77. DOI: 10.1007/s10856-008-3395-4. View

17.

Schilling A, Linhart W, Filke S, Gebauer M, Schinke T, Rueger J . Resorbability of bone substitute biomaterials by human osteoclasts. Biomaterials. 2004; 25(18):3963-72. DOI: 10.1016/j.biomaterials.2003.10.079. View

18.

Rousselle A, Heymann D, Demais V, Charrier C, Passuti N, Basle M . Influence of metal ion solutions on rabbit osteoclast activities in vitro. Histol Histopathol. 2002; 17(4):1025-32. DOI: 10.14670/HH-17.1025. View

19.

Botelho C, Brooks R, Spence G, McFarlane I, Lopes M, Best S . Differentiation of mononuclear precursors into osteoclasts on the surface of Si-substituted hydroxyapatite. J Biomed Mater Res A. 2006; 78(4):709-20. DOI: 10.1002/jbm.a.30726. View

20.

Dorozhkin S, Epple M . Biological and medical significance of calcium phosphates. Angew Chem Int Ed Engl. 2002; 41(17):3130-46. DOI: 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1. View